Actively Recruiting
Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model
Led by Inotrem · Updated on 2025-02-27
40
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
Sponsors
I
Inotrem
Lead Sponsor
I
IRCCS San Raffaele
Collaborating Sponsor
AI-Summary
What this Trial Is About
TIME is an observational study performed on UC and CD patients under endoscopic surveillance for monitoring the clinical activity of their disease. The main objective of the study is to confirm the therapeutic potential of TREM-1 in inflammatory bowel disease.
CONDITIONS
Official Title
Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients between 18 and 60 years
- Signed informed consent
- Ulcerative colitis (UC) patients with active disease
- Crohn's disease (CD) patients with active disease
You will not qualify if you...
- UC or CD patients in remission
- Patients between 18 and 60 years without informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS San Raffaele
Milan, Italy
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here